Repurposing Diabetes drugs for Alzheimer’s disease. View pathways associated with the action of Exenatide in Alzheimer’s. Explore the mechanism of action of GLP-1/GIP dual agonists in Alzheimer’s with Biovista Vizit.
Tags: ALZHEIMER'S DISEASE, CELL DEATH, CELL DIFFERENTIATION, DIABETES, EXENATIDE, GIP, GLP-1, INFLAMMATORY RESPONSE, LIPID METABOLIC PROCESS, LIRAGLUTIDE, METFORMIN, NEURON DEATH, SAXAGLIPTIN, SITAGLIPTIN PHOSPHATE